Biology of Blood and Marrow Transplantation
Volume 13, Issue 3 , Pages 245-254 , March 2007

A Process to Facilitate Decision Making in Pediatric Stem Cell Transplantation: The Individualized Care Planning and Coordination Model

  • Justin N. Baker

      Affiliations

    • Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Palliative and End-of-Life Care Task Force, St Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Raymond Barfield

      Affiliations

    • Department of Stem Cell Transplantation, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Palliative and End-of-Life Care Task Force, St Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Pamela S. Hinds

      Affiliations

    • Division of Nursing Research, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Palliative and End-of-Life Care Task Force, St Jude Children’s Research Hospital, Memphis, Tennessee
    • ,
  • Javier R. Kane

      Affiliations

    • Department of Oncology, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Palliative and End-of-Life Care Program, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Palliative and End-of-Life Care Task Force, St Jude Children’s Research Hospital, Memphis, Tennessee
    • Corresponding Author InformationCorrespondence and reprint requests: Dr. Javier Kane, St. Jude Children’s Research Hospital, 332 N. Lauderdale Drive, MS 260, Memphis, TN 38105.

Received 11 October 2006 ,Accepted 13 November 2006.

References 

  1. Apter A, Farbstein I, Yaniv I. Psychiatric aspects of pediatric cancer. Child Adolesc Psychiatr Clin N Am. 2003;12:473–492vii
  2. Packman WL, Crittenden MR, Schaeffer E, et al. Psychosocial consequences of bone marrow transplantation in donor and nondonor siblings. J Dev Behav Pediatr. 1997;18:244–253
  3. Nespoli L, Verri AP, Locatelli F, et al. The impact of paediatric bone marrow transplantation on quality of life. Qual Life Res. 1995;4:233–240
  4. Devine SM, Adkins DR, Khoury H, et al. Recent advances in allogeneic hematopoietic stem cell transplantation. J Lab Clin Med. 2003;141:7–32
  5. Uderzo C, Valsecchi MG, Balduzzi A, et al. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission (Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO)). Br J Haematol. 1997;96:387–394
  6. Woods WG. Curing childhood acute myeloid leukemia (AML) at the halfway point: promises to keep and miles to go before we sleep. Pediatr Blood Cancer. 2006;46:565–569
  7. Bosi A, Laszlo D, Labopin M, et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol. 2001;19:3675–3684
  8. Bradshaw G, Hinds PS, Lensing S, et al. Cancer-related deaths in children and adolescents. J Palliat Med. 2005;8:86–95
  9. Olson MS, Hinds PS, Euell K, et al. Peak and nadir experiences and their consequences described by pediatric oncology nurses. J Pediatr Oncol Nurs. 1998;15:13–24
  10. Field MJ, Behrman RE. When Children Die: Improving Palliative and End-of-Life Care for Children and Their Families. Washington DC: National Academies Press; 2003;
  11. Chen AR, Alonzo TA, Woods WG, et al. Current controversies: which patients with acute myeloid leukaemia should receive bone marrow transplantation? (An American view). Br J Haematol. 2002;118:378–384
  12. Diaz MA, Vicent MG, Prudencio M, et al. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica. 2002;87:292–298
  13. Hankins J, Hinds P, Day S, et al. Therapy preference and decision making among patients with severe sickle cell anemia and their families. Pediatr Blood Cancer. 2006;26:Epub ahead of print
  14. Morgan ER, Girod J, Rinehart JS. Having a child to save a sibling: reassessing risks and benefits of creating stem cell donors. Pediatr Blood Cancer. 2006;17:Epub ahead of print
  15. Pulsipher MA. Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?. Pediatr Blood Cancer. 2004;43:523–533
  16. Massimo L. Ethical problems in bone marrow transplantation in children. Bone Marrow Transplant. 1996;18(Suppl 2):8–12
  17. Himelstein BP, Hilden JM, Boldt AM, et al. Pediatric palliative care. N Eng J Med. 2004;350:1752–1762
  18. Hammes BJ, Klevan J, Kempf M, et al. Pediatric advance care planning. J Palliat Med. 2005;8:766–773
  19. O’Connor AM, Stacey D, Entwistle V, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;(Issue 1):Art. No.: CD001431. DOI:10.1002/14651858.CD001431
  20. Browning D. To show our humanness: relational and communicative competence in pediatric palliative care. Bioethics Forum. 2002;18:23–28
  21. Beale EA, Baile WF, Aaron J. Silence is not golden: communicating with children dying from cancer. J Clin Oncol. 2005;23:3629–3631
  22. The American Heritage Dictionary of the English Language. 4th ed. Available at: http://dictionary.reference.com/search?q=empathy. Accessed September 7, 2006.
  23. The American Heritage Dictionary of the English Language. 4th ed. Available at http://dictionary.reference.com/search?q=compassion. Accessed September 7, 2006.
  24. Institute of Medicine of the National Academies. Priority Areas for National Action: Transforming Health Care Quality. Washington, DC: National Academies Press; 2001;
  25. National Consensus Project for Quality Palliative Care (2004). Clinical practice guidelines for quality palliative care. Available at: http://www.nationalconsensusproject.org. Accessed September 12, 2006.
  26. Contro N, Larson J, Scofield S, et al. Family perspectives on the quality of pediatric palliative care. Arch Pediatr Adolesc Med. 2002;156:14–19
  27. Kim SS, Kaplowitz S, Johnston MV. The effects of physician empathy on patient satisfaction and compliance. Eval Health Prof. 2004;27:237–235
  28. Hinds PS, Oakes L, Furman W, et al. Decision making by parents and healthcare professionals when considering continued care for pediatric patients with cancer. Oncol Nurs Forum. 1997;24:1523–1528
  29. Tesser A, Rosen S, Tesser M. On the reluctance to communicate undesirable messages (the MUM effect) (A field study). Psychol Rep. 1971;29:651–654
  30. Tesser A, Conlee MC. Recipient emotionality as a determinant of the transmission of bad news. Proc Am Psychiatric Assoc. 1973;247–248
  31. Hilden JM, Emanuel EJ, Fairclough DL, et al. Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol. 2001;19:205–212
  32. Baile WF, Buckman R, Lenzi R, et al. SPIKES: A six-step protocol for delivering bad news (Application to the patient with cancer). Oncologist. 2000;5:302–311
  33. Masera G, Chesler MA, Jankovic M, et al. SIOP working committee on psychosocial issues in pediatric oncology: guidelines for communication of the diagnosis. Med Pediatr Oncol. 1997;28:382–385
  34. Hines SC, Glover JJ, Babrow AS, et al. Improving advance care planning by accommodating family preferences. J Palliat Med. 2001;4:481–489
  35. Meyer EC, Ritholz MD, Burns JP, et al. Improving the quality of end-of-life care in the pediatric intensive care unit: parents’ priorities and recommendations. Pediatrics. 2006;117:649–657
  36. Jones BL. Companionship, control, and compassion: a social work perspective on the needs of children with cancer and their families at the end of life. J Palliat Med. 2006;9:774–788
  37. Hinds PS, Drew D, Oakes LL, et al. End-of-life care preferences of pediatric patients with cancer. J Clin Oncol. 2005;23:9146–9154
  38. The National Quality Forum Review Committee. National Framework and Preferred Practices for Palliative and Hospice Care, prerelease. Available at: http://www.qualityforum.org/publications/. Accessed September 15, 2006.
  39. Hinds PS, Kelly KP. Studying clinical decision making by patients, parents, and healthcare providers in pediatric oncology. J Pediatr Oncol Nurs. 1998;15:1–2
  40. Hinds PS, Oakes L, Furman WL, et al. End-of-life decision making by adolescents, parents, and health care providers in pediatric oncology: research to evidence-based practice guidelines. Cancer Nurs. 2001;24:122–134
  41. Wolfe J, Klar N, Grier HE, et al. Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care. JAMA. 2000;84:2469–2475
  42. Weitman S, Ochoa S, Sullivan J, et al. Pediatric phase II cancer chemotherapy trials. J Pediatr Hematol Oncol. 1997;19:187–191
  43. Shah S, Weitman S, Langevin AM. Phase I trial in children with cancer. J Pediatr Hematol Oncol. 1998;20:136–139
  44. Kane JR, Primomo M. Alleviating the suffering of seriously ill children. Am J Hospice Palliat Care. 2001;18:1–9
  45. West HF, Engelberg RA, Wenrich MD, et al. Expressions of nonabandonment during the intensive care unit family conference. J Palliat Med. 2005;8:797–807
  46. McDonagh JR, Elliott TB, Engelberg RA, et al. Family satisfaction with family conferences about end-of-life care in the intensive care unit: increased proportion of family speech is associated with increased satisfaction. Crit Care Med. 2004;32:1484–1488
  47. Barrera M, D’Agostino N, Gammon J, et al. Health-related quality of life and enrollment in phase 1 trials in children with incurable cancer. Palliat Support Care. 2005;3:191–196
  48. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ. 1999;319:766–771
  49. Kane JR, Hellsten MB, Coldsmith A. The need for relationship-based research in pediatric end of life care. J Pediatr Oncol Nurs. 2004;21:180–185
  50. Hays RM, Valentine J, Haynes G, et al. The Seattle Pediatric Palliative Care Project: effects on family satisfaction and health-related quality of life. J Palliat Med. 2006;9:716–728
  51. Whitney SN, Ethier AM, Fruge E, et al. Decision making in pediatric oncology: who should take the lead? (The decisional priority in pediatric oncology model). J Clin Oncol. 2006;24:160–165
  52. Maltoni M, Caraceni A, Brunelli C, et al. Steering Committee of the European Association for Palliative Care (Prognostic factors in advanced cancer patients: evidence-based clinical recommendationsA study by the Steering Committee of the European Association for Palliative Care). J Clin Oncol. 2005;23:6240–6248
  53. American Academy of Pediatrics. Medical home initiatives for children with special health care needs advisory committee (The medical home). Pediatrics. 2004;113:1545–1547
  54. Kane JR, Himelstein BP. Palliative care for children. In:  Berger A,  Portenoy R editor. Principles and Practice of Palliative Care and Supportive Oncology. 3rd ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2006;
  55. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia. 2005;19:2101–2116
  56. Lorenz K, Lynn K, Dy S, et al. Cancer care quality measures: symptoms and end-of-life care. Evidence report/technology assessment 137, prepared by the Southern California Evidence-Based Practice Center, 2006.

PII: S1083-8791(06)00772-5

doi: 10.1016/j.bbmt.2006.11.013

Biology of Blood and Marrow Transplantation
Volume 13, Issue 3 , Pages 245-254 , March 2007

Article Tools

* Image Usage & Resolution